tyrosyl-arginyl-phenylalanyl-lysinamide has been researched along with Reperfusion Injury in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goldsmith, JR; Jobin, C; Perez-Chanona, E; Roth, B; Whistler, J; Yadav, PN | 1 |
1 other study(ies) available for tyrosyl-arginyl-phenylalanyl-lysinamide and Reperfusion Injury
Article | Year |
---|---|
Intestinal epithelial cell-derived μ-opioid signaling protects against ischemia reperfusion injury through PI3K signaling.
Topics: Animals; Apoptosis; Cytoprotection; Enterocytes; Epithelial Cells; Gene Deletion; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Intestines; Ligands; Mice; Mice, Inbred C57BL; Oligopeptides; Organ Specificity; Phosphatidylinositol 3-Kinases; Phosphorylation; Protective Agents; Receptors, Opioid, mu; Reperfusion Injury; Signal Transduction | 2013 |